WuXi AppTec Inc. announced that it has entered into partnership with QIAGEN to provide an integrated single solution for molecular biomarker development. The laboratory will be located at WuXi AppTec's campus in Shanghai and will begin operating immediately.
Pursuant to deal, QIAGEN will provide a complete portfolio of instrumentation, training, and consumables and WuXi AppTec will provide laboratory facilities and staff to execute the services.
Under the terms of deal, WuXi AppTec will also work with QIAGEN to help develop biomarkers, assay panels, personalized healthcare diagnostics, and other products that QIAGEN intends to bring to market. WuXi AppTec and QIAGEN will also co-promote each other's services to their respective customers.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.